Lucid Diagnostics (LUCD) Depreciation and Depletion (2021 - 2022)

Lucid Diagnostics (LUCD) reported Depreciation and Depletion of $24000.0 for Q1 2022, up 700.0% on a YoY basis from $3000.0 in Q1 2021, and up 4216.55% quarter-over-quarter from $556.0 in Q4 2021.

Lucid Diagnostics (LUCD) Depreciation and Depletion (2021 - 2022) Analysis & Trends

Lucid Diagnostics has reported Depreciation and Depletion for 2 years, with the latest figure at $24000.0 in Q1 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 381.00 Mn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 120.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 308.00 Mn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 29.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 78.00 Mn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Lucid Diagnostics 149.20 Mn 121.33 Mn -325,000.00 -

Historic Data

Download Data
DateValue
Mar 31, 2022 24,000.00
Mar 31, 2022 24,000.00
Dec 31, 2021 556.00
Dec 31, 2021 556.00
Mar 31, 2021 3,000.00
Mar 31, 2021 3,000.00